16
Jun
2026

Korea United Pharm. Inc.

Exhibitor at CPHI & PMEC China 2026 stand E1D15, Pharma Ingredients
About Us

As one of the leading pharmaceutical companies in Korea, we've been contributing to the public healthcare of the world as well as Korea with a wide range of innovative products including IMD (Incrementally Modifed Drug) and Oncology products. We are currently exporting our products to over 50 countries and operating branches in the Philippines, Vietnam, Indonesia, Myanmar, and Thailand. In addition, we've been making efforts to constantly develop innovative products through R&D investment which accounts for over 12% of annual turnover.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2015
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1D15, Pharma Ingredients

Products Featured at CPHI & PMEC China 2026

  • CILOSTAN (Cilostazol) CR Tab.

    Product CILOSTAN (Cilostazol) CR Tab.

    Anti-platelet agent.It contains Cilostazol 200 mg.Administration: Once Daily, One Tablet (Controlled Release Tablet).
  • CLANZA (Aceclofenac) CR Tab.

    Product CLANZA (Aceclofenac) CR Tab.

    NSAIDs.It contains Aceclofenac 200 mg.Administration: Once Daily, One Tablet (Controlled Release Tablet).
  • GASTIIN (Mosapride) CR Tab.

    Product GASTIIN (Mosapride) CR Tab.

    Prokinetics.It contains Mosapride citrate 15 mg.Administration: Once Daily, One Tablet (Controlled Release Tablet).
  • Augmex Duo Tabs 500mg

    Product Augmex Duo Tabs 500mg

    Korea United Pharm. Inc provides wide range of pharmaceutical products which includes augmex duo tabs 500mg. It belongs to anti-infectives category. Indications and uses: acute and chronic bronchitis, lobar and bronchial pneumonia, tonsillitis, tympanitis, empyema, cystitis, urethritis, nephropyelitis, mye...
  • TEZOMIN for inj. (Bortezomib)

    Product TEZOMIN for inj. (Bortezomib)


    Anti-cancer.
    It contains Bortezomib 2.5mg, 3.5mg.
    Form: Lyophilized.

Korea United Pharm. Inc. Resources (1)